These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33254378)

  • 21. Predictors of Adherence to Lifestyle Recommendations in Stroke Secondary Prevention.
    Lennon O; Hall P; Blake C
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of long-term medication adherence in stroke survivors: A multicentre, prospective, longitudinal study.
    Yoo SH; Kim GG; Kim SR; Park MS; Kim JT; Choi KH; Park HY; Yi SH; Cha JK; Kim DH; Nah HW
    J Clin Nurs; 2023 Jan; 32(1-2):58-70. PubMed ID: 35922959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
    Rodriguez F; Cannon CP; Steg PG; Kumbhani DJ; Goto S; Smith SC; Eagle KA; Ohman EM; Umez-Eronini AA; Hoffman E; Bhatt DL;
    Clin Cardiol; 2013 Dec; 36(12):721-7. PubMed ID: 24166484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.
    Rajpura J; Nayak R
    J Manag Care Pharm; 2014 Jan; 20(1):58-65. PubMed ID: 24511766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-taking after stroke: a qualitative meta-synthesis of the perspectives of stroke survivors, informal carers and health professionals.
    Gibson JME; Miller C; Coupe J; Jones SP
    Fam Pract; 2020 Feb; 37(1):4-14. PubMed ID: 31324915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are the patient-held illness beliefs after a transient ischaemic attack, and do they determine secondary prevention activities: an exploratory study in a North London General Practice.
    Kamara S; Singh S
    Prim Health Care Res Dev; 2012 Apr; 13(2):165-74. PubMed ID: 22433271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIA.
    Lane D; Beishon L; Sharma V; Salim F; Sze S; Timmins MA; Robinson T; Eveson D; Mistri A; Patel P; Gupta P
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106665. PubMed ID: 35901588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of adherence to secondary preventive medication in stroke patients.
    O'Carroll R; Whittaker J; Hamilton B; Johnston M; Sudlow C; Dennis M
    Ann Behav Med; 2011 Jun; 41(3):383-90. PubMed ID: 21193977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary preventive medication persistence and adherence 1 year after stroke.
    Bushnell CD; Olson DM; Zhao X; Pan W; Zimmer LO; Goldstein LB; Alberts MJ; Fagan SC; Fonarow GC; Johnston SC; Kidwell C; Labresh KA; Ovbiagele B; Schwamm L; Peterson ED;
    Neurology; 2011 Sep; 77(12):1182-90. PubMed ID: 21900638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: Insights from registry data in Singapore.
    Yeo SH; Toh MPHS; Lee SH; Seet RCS; Wong LY; Yau WP
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):538-549. PubMed ID: 32190948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary stroke prevention among stroke survivors in Riyadh city, Saudi Arabia. Risk Knowledge, adherence to stroke discharge medications and preventive strategies.
    Alhusayni SF; Abanmi NM; Abanemai NA; Alharbi RM; AlAtiyah FA; Abdalla SM; Alharbi AA
    Neurosciences (Riyadh); 2020 Apr; 25(2):118-128. PubMed ID: 32351249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria.
    Adisa R; Ilesanmi OA; Fakeye TO
    BMC Cardiovasc Disord; 2018 Oct; 18(1):194. PubMed ID: 30340528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between adherence to secondary prevention and health literacy, self-efficacy and disease knowledge among patients with coronary artery disease in China.
    Lu M; Xia H; Ma J; Lin Y; Zhang X; Shen Y; Hravnak M
    Eur J Cardiovasc Nurs; 2020 Mar; 19(3):230-237. PubMed ID: 31595771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of Use and Discontinuation of Secondary Prevention Medications After Stroke.
    Dalli LL; Kim J; Thrift AG; Andrew NE; Sanfilippo FM; Lopez D; Grimley R; Lannin NA; Wong L; Lindley RI; Campbell BCV; Anderson CS; Cadilhac DA; Kilkenny MF;
    Neurology; 2021 Jan; 96(1):e30-e41. PubMed ID: 33093227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort.
    Rohde D; Gaynor E; Large M; Mellon L; Bennett K; Williams DJ; Brewer L; Hall P; Callaly E; Dolan E; Hickey A
    PLoS One; 2019; 14(10):e0223997. PubMed ID: 31622438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia.
    Alfian SD; Annisa N; Fajriansyah F; Perwitasari DA; Abdulah R; Hak E; Denig P
    J Gen Intern Med; 2020 Oct; 35(10):2897-2906. PubMed ID: 32301043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimisation of secondary prevention of stroke: a qualitative study of stroke patients' beliefs, concerns and difficulties with their medicines.
    Souter C; Kinnear A; Kinnear M; Mead G
    Int J Pharm Pract; 2014 Dec; 22(6):424-32. PubMed ID: 24606322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review.
    Lennon O; Galvin R; Smith K; Doody C; Blake C
    Eur J Prev Cardiol; 2014 Aug; 21(8):1026-39. PubMed ID: 23478741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Adherence to Secondary Stroke Prevention Strategies Through Motivational Interviewing: Randomized Controlled Trial.
    Barker-Collo S; Krishnamurthi R; Witt E; Feigin V; Jones A; McPherson K; Starkey N; Parag V; Jiang Y; Barber PA; Rush E; Bennett D; Aroll B
    Stroke; 2015 Dec; 46(12):3451-8. PubMed ID: 26508749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.